已收盘 08-21 16:00:00 美东时间
+1.580
+4.38%
今日重点评级关注:康托·菲茨杰拉德:维持InflaRx"超配"评级,目标价从4美元升至6美元;RBC Capital:维持Nuvation Bio"跑赢大市"评级,目标价从19美元升至20美元
08-10 19:24
Wells Fargo analyst Tiago Fauth maintains Tectonic Therapeutic (NASDAQ:TECX) with a Overweight and lowers the price target from $101 to $93.
08-07 21:58
Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.18) per share which beat the analyst consensus estimate of $(1.37) by 13.87 percent. This is a 10.28 percent decrease over losses of $(1.07) per share from the same period last year.
08-07 05:44
今日重点评级关注:Canaccord Genuity:维持Dakota Gold"投机性买入"评级,目标价从16美元升至18美元;瑞杰金融:上调Tectonic Therapeutic评级至"强烈买入",目标价从76美元升至81美元
05-27 17:33
Raymond James analyst Michael Freeman upgrades Tectonic Therapeutic (NASDAQ:TECX) from Outperform to Strong Buy and raises the price target from $76 to $81.
05-27 01:15
Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.34) per share which missed the analyst consensus estimate of $(1.18) by 13.56 percent. This is a 44.09 percent decrease over losses of $(0.93) per share
05-08 04:29
今日重点评级关注:Ascendiant Capital:维持Banzai International"买入"评级,目标价从23美元升至24美元;Ascendiant Capital:维持Synergy CHC Corp."买入"评级,目标价从5美元升至5.5美元
04-15 11:31
Stifel analyst James Condulis initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Buy rating and announces Price Target of $75.
04-14 19:42
Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.03) per share which beat the analyst consensus estimate of $(1.10) by 6.53 percent. This is a 22.62 percent decrease over losses of $(0.84) per share
02-27 05:54